2022 May

PD-MitoQUANT research presented at Dutch Translational Metabolism Conference

pdmq_admin2022-05-30T13:16:29+01:00May 30th, 2022|News, Partner in the Spotlight|

Post-doc Dr Shruti Desai of the Radboud University Nijmegen Medical Centre (RUMC) and Sandeep Chenna of the RCSI will present PD-MitoQUANT research at the 2022 Dutch Translational Metabolism Conference, which will be held in Wageningen on June 13th and 14th (https://www.translationalmetabolism.nl/). Shruti's poster is titled: PD-MitoQUANT: Quantification of Mitochondrial Morphofunction in hiPSC- derived Cortical Neurons. Sandeep's is titled: Systems modelling of mitochondrial bioenergetics and genome scale metabolic modelling to explore molecular defects contributing to pathogenesis in Parkinson’s. The aim of the [...]

PD-MitoQUANT team publication in Cells journal

pdmq_admin2022-05-16T11:42:13+01:00May 16th, 2022|News, Publication|

Congratulations to the PD-MitoQUANT team of Aurore Tourville, David Akbar, Olga Corti, Jochen H. M. Prehn, Ronald Melki, Stéphane Hunot and Patrick P. Michel from ICM, CNRS and RCSI for the publication of their open-access study titled: Modelling α-Synuclein Aggregation and Neurodegeneration with Fibril Seeds in Primary Cultures of Mouse Dopaminergic Neurons in Cells on May 13th, 2022. Citation: Tourville, A.; Akbar, D.; Corti, O.; Prehn, J.H.M.; Melki, R.; Hunot, S.; Michel, P.P. Modelling α-Synuclein Aggregation and Neurodegeneration with Fibril Seeds [...]

Neuronet releases Decision Tool for engagement with Regulatory and Health Technology Assessment bodies

pdmq_admin2022-05-11T15:15:58+01:00May 11th, 2022|News|

Neuronet (Efficiently Networking European Neurodegeneration Research, https://www.imi-neuronet.org/) just launched a new version of their Decision Tool to support engagement with Regulatory and Health Technology Assessment (HTA) bodies. The Decision Tool provides a clickable overview of the processes and procedures for HTA and regulatory interactions at different stages of the development pipeline to help ensure that the outputs being developed by Innovative Medicines Initiative research projects are relevant for regulatory and HTA settings, where applicable. Neuronet, a Coordination and Support Action [...]

Prof. Ronald Melki is co-organizer of Protein phase transitions in aging and age-related diseases conference

pdmq_admin2022-05-03T15:35:47+01:00May 3rd, 2022|News, Partner in the Spotlight|

PD-MitoQUANT PI Prof. Dr Ronald Melki, CNRS, Fontenay-aux-Roses, France is the co-organizer of the Protein phase transitions in aging and age-related diseases: from atomic resolution to cellular solutions conference which will take place in Roscoff, Brittany, France from October 17th through the 21st, 2022. The deadline for applications is June 13th; click here for application guidelines. Invited speakers include PI Dr Olga Corti, ICM, who will speak about Mitochondrial quality control in Parkinson's disease and Ronald Melki, CNRS: Fibril polymorphisms and propagation About [...]